stockrow
Friday 6 November 2026
Export HSTM’s income statement to Excel — free account
HealthStream, Inc.
HSTM Healthcare Health Information Services
HealthStream, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $304.1 million, up 4.26% from fiscal 2024.
- Revenue
- +8.94%
- EPS
- −8.90%
- Free cash flow
- −4.80%
Quarter to September 2026, against a year earlier
28.78
0.82
−2.77%
Follow HSTM
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
42.31 | 37.85 | 30.91 | 37.82 |
+8 more quarters Free account |
P/S ratio |
2.67 | 2.48 | 1.95 | 2.28 | |
P/FCF ratio |
12.70 | 11.40 | 10.13 | 11.60 | |
P/Operating CF |
50.38 | 59.30 | 22.42 | 52.50 | |
P/B ratio |
2.18 | 2.23 | 1.73 | 1.96 | |
Price to Tangible BV |
6.60 | 9.49 | 8.04 | 9.68 | |
EV/Sales |
2.41 | 2.36 | 1.83 | 2.18 | |
EV/EBITDA |
9.42 | 9.04 | 7.10 | 8.69 | |
EV/Operating CF |
11.09 | 10.56 | 8.99 | 10.48 | |
EV/FCF |
11.43 | 10.85 | 9.49 | 11.12 | |
Quick Ratio |
1.27 | 0.84 | 0.81 | 0.77 | |
Current Ratio |
1.48 | 1.06 | 0.97 | 0.96 | |
Net Debt/EBITDA |
0.00 | (2.88) | (3.00) | (3.38) | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.62 | 0.63 | 0.59 | 0.59 | |
Operating CF/Net income |
3.24 | 2.01 | 4.59 | 5.20 | |
Capex/Depreciation |
(0.02) | (0.06) | (0.05) | (0.01) | |
Research and Development Expense of Revenue |
16.23% | 16.22% | 16.76% | 18.51% | |
Selling, General and Administrative Expense of Revenue |
26.31% | 25.72% | 25.81% | 28.43% | |
Intangible Assets out of Total Assets |
0.48 | 0.52 | 0.52 | 0.54 | |
Share Based Compensation of Revenue |
1.44% | 1.32% | 1.61% | 6.79% | |
Graham Net Nets |
0.02 | (0.04) | (0.07) | (0.07) | |
Graham Number |
14.67 | 14.06 | 13.44 | 12.72 | |
Earnings Yield |
2.36% | 2.64% | 3.24% | 2.64% | |
Free Cash Flow Yield |
7.88% | 8.77% | 9.87% | 8.62% | |
Revenue per Share |
2.82 | 2.86 | 2.76 | 2.66 | |
Operating CF per Share |
0.59 | 0.46 | 0.92 | 0.44 | |
Capex per Share |
(0.01) | (0.03) | (0.03) | (0.01) | |
Free Cash Flow per Share |
0.58 | 0.43 | 0.90 | 0.43 | |
Cash per Share |
3.91 | 2.28 | 2.26 | 1.90 | |
Shareholders Equity per Share |
13.63 | 12.20 | 11.98 | 11.79 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
13.63 | 12.20 | 11.98 | 11.79 | |
Free Cash Flow |
17.06 | 12.52 | 26.40 | 13.03 | |
Working Capital |
58.17 | 7.59 | (3.49) | (4.49) | |
Capital Expenditures |
(0.33) | (0.91) | (0.74) | (0.16) | |
Net Current Asset Value |
15.45 | (34.77) | (42.43) | (46.69) | |
EV/EBIT |
31.78 | 29.37 | 24.39 | 32.79 | |
Capex to Sales |
0.00 | 0.01 | 0.01 | 0.00 | |
Price to Operating Income |
35.29 | 30.87 | 26.03 | 34.22 | |
| Other line items | |||||
Average Receivables |
36.22 | 34.14 | 39.77 | 37.16 | |
Average Payables |
16.63 | 5.43 | 4.13 | 7.20 | |
Average Assets |
532.89 | 510.87 | 525.74 | 515.57 | |
Average Common Equity |
375.57 | 353.59 | 357.40 | 356.69 |
Columns are period end dates · fundamentals updated 5 Nov 2026